Status:
COMPLETED
FRench Elective Oocyte prEservation: a Multicenter Study thrEe Years Later
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
Elective Fertility Preservation
Eligibility:
FEMALE
29-37 years
Brief Summary
Previously reserved for pathological cases, oocyte cryopreservation for non-medical reason also named elective fertility preservation (EFP) is now authorized in France for women aged 29 to 37 followin...
Detailed Description
This is a multicenter descriptive study conducted by the AMP-CECOS unit of the Clermont-Ferrand University Hospital between November 2023 and June 2024, with the participation of CECOS centers across ...
Eligibility Criteria
Inclusion
- Being in SFP process
- Undergone SFP
- 29 to 37 years of age at the time of SFP or process
Exclusion
- Women who had criteria for medical fertility preservation
Key Trial Info
Start Date :
November 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
351 Patients enrolled
Trial Details
Trial ID
NCT07138469
Start Date
November 1 2023
End Date
June 30 2024
Last Update
August 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Clermont-Ferrand
Clermont-Ferrand, Auvergne, France, 63000